Study Shows Two-Year Clinical Benefits for Kidney Disease Risk Test
A two-year real-world study of Renalytix’s FDA-approved KidneyIntelX.dkd test showed improved kidney function and targeted treatment in 2,470 patients with type 2 diabetes.
Category: Diabetes & Metabolic Diseases
Diabetes & Metabolic Diseases
Latest
Diabetes & Metabolic Diseases
Latest
HistoIndex Partners with Houston Research Institute for MASH Diagnostic Services
HistoIndex and Houston Research Institute have partnered to offer AI-driven pathology analysis for metabolic dysfunction-associated steatohepatitis across four HRI centers in Texas, expanding advanced diagnostic services for liver disease.
Diabetes & Metabolic Diseases
Latest
PRO-C3 Launched by Roche Diagnostics on cobas Analyzers
Nordic Bioscience's PRO-C3 test, now launched globally by Roche Diagnostics on cobas analyzers, offers a way to assess liver fibrosis.
Widely Used Test for Gestational Diabetes Misses 70% of Cases
A new study encourages the use of more reliable tests to prevent pregnancy complications and the development of type II diabetes.
Read More
Blood Test Could Predict Cancer Risk in Type 2 Diabetes Patients
A blood test measuring IL-6 levels may help identify those with type 2 diabetes who are at high risk of developing obesity-related cancers.
Read More
‘Band-Aid’ That Measures Glucose Levels in Sweat Developed
Scientists have developed a “band-aid” that measures biomarkers, including glucose levels, in sweat to monitor health conditions.
Read More
New Research Quantifies Impacts of a Type 1 Diabetes Diagnosis
A new survey highlights the significant emotional, social, and financial impacts of a type 1 diabetes diagnosis on adults and caregivers.
Read More
New Biomarkers Found to Predict Kidney Failure in Type 1 Diabetes Patients
Researchers discovered biomarkers that can predict kidney failure in type 1 diabetes patients, potentially providing early detection methods.
Read More
Non-Invasive Liver Disease Blood Test Hits the U.S. Market
Luxor Scientific and CIMA Sciences have launched OWLiver, a non-invasive blood test to detect all stages of metabolic liver disease.
Read More
Blood Test Could Determine Diabetes Risks
A blood test could potentially be used to assess a patient’s risk of type 2 diabetes, a new study from Edith Cowan University has found.Â
Read More
How cfDNA Sequencing Can Enhance Non-Invasive Detection of Gestational Diabetes
A new study aimed to develop a non-invasive method for early detection of GDM using cell-free DNA (cfDNA) and deep learning models.
Read More
New Mathematical Model Detects Diabetes Early
A mathematical calculation based on two values taken from blood enables the reliable and inexpensive diagnosis of diabetes at an early stage.
Read More
FDA Clears Qvin Test that Uses Menstrual Blood
The clearance makes it possible for women who live with diabetes to receive monitoring of A1c, using laboratory tests performed on the Q-Pad.
Read More
Two-Step Screening Strategy Could Reduce Diabetic Heart Failure
A two-step screening protocol can effectively identify which patients with Type 2 diabetes need medication to prevent heart failure.
Read More
Identifying New Methods of Gestational Diabetes Diagnosis
A new study evaluated the diagnostic value of certain markers before or at the time of screening for gestational diabetes mellitus.
Read More
New Biosensors Use Saliva for At-Home Health Monitoring
Researchers developed a device that detects glucose and adenosine monophosphate (AMP) biomarkers in saliva with high sensitivity.
Read More
New Biomarker Predicts Non-Lymphocytic Lesions in Central Diabetes Insipidus Patients
Researchers show that patients with central diabetes insipidus who lack anti-rabphilin-3A antibodies could be at risk of tumor development
Read More
Using AI and a Person’s Voice to Screen for Diabetes
Determining whether a person is diabetic could be as easy as having them speak a few sentences into their smartphone, a new study found.
Read More